Target Identification/Validation with ECS Drug

Time: 11:55 am
day: Day 2 Track B - Morning

Details:

  • In the context of Medpharm’s current research into degenerative disease, discuss key ideas involved in the
    phase 1 study design process
  • Consider key target identification principles

Speakers: